Xtant Medical Holdings, Inc.
XTNT
Rank in Stocks
#23758
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes... Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
Share Price
$0.279
Last synced: 2026-11-09
Market Cap
$39.14M
Change (1 day)
-3.59%
Change (1 year)
-63.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Xtant Medical Holdings, Inc. (XTNT)
Category
Healthcare
Operating Margin for Xtant Medical Holdings, Inc. (XTNT)
Operating Margin as of November 2026 TTM: -9.58%
According to Xtant Medical Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -9.58%. At the end of 2025 the company had an operating margin of 5.44%.
Operating Margin history for Xtant Medical Holdings, Inc. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -9.58% | -276.10% |
| 2025 | 5.44% | -152.82% |
| 2024 | -10.30% | -7.46% |
| 2023 | -11.13% | -4.46% |
| 2022 | -11.65% | 67.14% |
| 2021 | -6.97% | 394.33% |
| 2020 | -1.41% | -61.26% |
| 2019 | -3.64% | -95.63% |
| 2018 | -83.21% | 81.68% |
| 2017 | -45.80% | 446.54% |
| 2016 | -8.38% | -58.82% |
| 2015 | -20.35% | 14.78% |
| 2014 | -17.73% | -34.91% |
| 2013 | -27.24% | 81.72% |
| 2012 | -14.99% | -29.92% |
| 2011 | -21.39% | -61.71% |
| 2010 | -55.87% | 14.02% |
| 2009 | -49.00% | 1,320.29% |
| 2008 | -3.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -101.59% |
US
|
|
| 18.08% | -101.89% |
IE
|
|
| 21.25% | -102.22% |
US
|
|
| 21.05% | -102.20% |
US
|
|
| 28.09% | -102.93% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Xtant Medical Holdings, Inc.'s operating margin
What is Xtant Medical Holdings, Inc.'s operating margin?
Xtant Medical Holdings, Inc.'s operating margin is -9.58%, as of Nov 2026.
What was Xtant Medical Holdings, Inc.'s operating margin in 2025?
In 2025, Xtant Medical Holdings, Inc.'s operating margin was 5.44%, compared with -10.30% in 2024.
How has Xtant Medical Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Xtant Medical Holdings, Inc.'s operating margin was highest in 2025 (5.44%) and lowest in 2022 (-11.65%).
How does Xtant Medical Holdings, Inc.'s operating margin compare with similar companies?
Xtant Medical Holdings, Inc.'s operating margin (-9.58%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.